(Q45876638)

17 December 2017

title

Intratumoral IL-18 gene transfer improves therapeutic efficacy of antibody-targeted superantigen in established murine melanoma (English)

1 reference

17 December 2017

1 reference

Wang Q

1

1 reference

17 December 2017

Yu H

2

1 reference

17 December 2017

Ju DW

3

1 reference

17 December 2017

He L

4

1 reference

17 December 2017

Pan JP

5

1 reference

17 December 2017

Xia DJ

6

1 reference

17 December 2017

Zhang LH

7

1 reference

17 December 2017

Cao X

8

1 reference

17 December 2017

publication date

1 April 2001

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

8

1 reference

17 December 2017

issue

7

1 reference

17 December 2017

page(s)

542-550

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301428

exact match

0 references

cites work

FBL-reactive CD8+ cytotoxic and CD4+ helper T lymphocytes recognize distinct Friend murine leukemia virus-encoded antigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Monoclonal antibody-superantigen fusion proteins: tumor-specific agents for T-cell-based tumor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Tumor‐reactive superantigens suppress tumor growth in humanized scid mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Antibody-targeted superantigens are potent inducers of tumor-infiltrating T lymphocytes in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Superantigen-based immunotherapy: a phase I trial of PNU-214565, a monoclonal antibody-staphylococcal enterotoxin A recombinant fusion protein, in advanced pancreatic and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Phase I study of single, escalating doses of a superantigen-antibody fusion protein (PNU-214565) in patients with advanced colorectal or pancreatic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Comparative study of the antitumor effect of two types of murine recombinant interferons, (beta) and (gamma), against B16-F10 melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Tumor-selective cytotoxic effects of murine tumor necrosis factor (TNF) and interferon-gamma (IFN-gamma) in organ culture of B16 melanoma cells and heart tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Cloning of a new cytokine that induces IFN-gamma production by T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Interferon-gamma-inducing factor, a novel cytokine, enhances Fas ligand-mediated cytotoxicity of murine T helper 1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

In vivo antitumor effects of murine interferon-gamma-inducing factor/interleukin-18 in mice bearing syngeneic Meth A sarcoma malignant ascites

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Interleukin-18 gene transfer increases antitumor effects of suicide gene therapy through efficient induction of antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

The distinct role of CD4+ and CD8+ T-cells during the anti-tumour effects of targeted superantigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Anti-CD3-activated killer T cells: interferon-gamma and interleukin-10 cross-regulate granzyme B expression and the induction of major histocompatibility complex-unrestricted cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Expression of mouse mammary tumor virus superantigen accelerates tumorigenicity of myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Induction of potent antitumor response by vaccination with tumor lysate-pulsed macrophages engineered to secrete macrophage colony-stimulating factor and interferon-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

The Vβ-specific superantigen staphylococcal enterotoxin B: Stimulation of mature T cells and clonal deletion in neonatal mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

Superantigen-induced cytokines suppress growth of human colon-carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

7 January 2021

Immunotherapy of human colon cancer by antibody-targeted superantigens

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

7 January 2021

Antibody-targeted superantigen therapy induces tumor-infiltrating lymphocytes, excessive cytokine production, and apoptosis in human colon carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

7 January 2021

Immune response during tumor therapy with antibody-superantigen fusion proteins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

7 January 2021

Long-term survival and complete cures of B16 melanoma-carrying animals after therapy with tumor-targeted IL-2 and SEA

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

7 January 2021

Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

7 January 2021

Antitumor activity of interleukin-18 on mouse glioma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

1 reference

7 January 2021

Prevention of superantigen-induced tolerance in vivo by interleukin-2 treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

7 January 2021

Antitumor effects on mouse melanoma elicited by local secretion of interleukin-12 and their enhancement by treatment with interleukin-18

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

7 January 2021

Interleukin-18 acts as an angiogenesis and tumor suppressor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301428

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301428

1 reference

17 December 2017

Dimensions Publication ID

1051149181

0 references

1 reference

17 December 2017